Browsing: HCP Access Only

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

By KayeJanuary 13, 20230

Lenacapavir (Sunleca®), a first-in-class long-acting HIV-1 capsid function inhibitor, was approved by the FDA in December 2022

A New Paradigm in Severe Burn Treatment – FDA Approves Anacaulase (NexoBrid®)

By KayeJanuary 3, 20230

In Dec 2022, the US Food and Drug Administration (FDA) approved MediWound’s biologic license application (BLA) for anacaulase-bcdb (NexoBrid®)

Indonesia To Launch Takeda’s QDENGA Dengue Vaccine Jab in 2023

By MCA TeamDecember 9, 20220

QDENGA, a live-attenuated, dengue tetravalent vaccine, was approved by Indonesia’s BPOM for the prevention of dengue caused by any serotype.

Breakthrough Therapy: What You Need to Know about HIBRUKA (Orelabrutinib)

By MCA TeamDecember 9, 20220

InnoCare Pharma announced the approval of HIBRUKA (Orelabrutinib) by the HSA of Singapore for the treatment of adult patients with r/r MCL

Smoking Cessation: It’s all about the Questions – 5A’s and 5R’s

By ShanPingNovember 25, 20221

Terlivaz (Terlipressin) to Improve Kidney Function in Adults with Hepatorenal Syndrome

By KayeNovember 17, 20220

Evidence for Smoking Cessation after Cardiovascular Events – Part 2

By Rachel TanNovember 3, 20220

Two recent studies examined the effects of smoking cessation after cardiovascular events. One found quitters halved their odds of recurrent heart attack within 6 months. The other recorded indistinguishable mortality risks for quitters and nonsmokers after 4 years, whereas persistent smoking was associated with double the mortality risk.

A Summary of Pharmacotherapies for Smoking Cessation

By ShanPingNovember 3, 20220

Evidence for Smoking Cessation after Cardiovascular Events – Part 1

By ShanPingOctober 26, 20220

Gadopiclenol (Elucirem™) for Contrast-Enhanced MRI

By KayeOctober 20, 20220

The US FDA granted regulatory approval to Gadopiclenol (Elucirem™), a new macrocyclic GBCA for use in adults and children aged 2 years and older, for contrast-enhanced MRI.

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

5 Strategies for Doctors to Attract More Patients

The Placebo Effect of Vitamins: Belief vs Reality

Does Freezing Bread Really Lower Its Glycaemic Index?

Browsing: HCP Access Only

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

A New Paradigm in Severe Burn Treatment – FDA Approves Anacaulase (NexoBrid®)

Indonesia To Launch Takeda’s QDENGA Dengue Vaccine Jab in 2023

Breakthrough Therapy: What You Need to Know about HIBRUKA (Orelabrutinib)

Smoking Cessation: It’s all about the Questions – 5A’s and 5R’s

Terlivaz (Terlipressin) to Improve Kidney Function in Adults with Hepatorenal Syndrome

Evidence for Smoking Cessation after Cardiovascular Events – Part 2

A Summary of Pharmacotherapies for Smoking Cessation

Evidence for Smoking Cessation after Cardiovascular Events – Part 1

Gadopiclenol (Elucirem™) for Contrast-Enhanced MRI

5 Strategies for Doctors to Attract More Patients

The Placebo Effect of Vitamins: Belief vs Reality

Does Freezing Bread Really Lower Its Glycaemic Index?

How Telemedicine is Transforming The Way Singaporeans Manage Diabetes

Subscribe to Updates

What's Hot

Browsing: HCP Access Only

Subscribe to Updates